Concentrix CORP
Market Movers (8-K)
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation has updated its executive severance plan to align with market practices and provide enhanced benefits.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation announced its second quarter 2026 financial results, reporting revenue within guidance and a record-high $258 million in cash flow from operations.
NASDAQ
CNXC
Concentrix CORPBilge Ogut resigned from the Concentrix Board of Directors after GBL's ownership fell below the required threshold.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation's stockholders approved an amendment to its 2020 Stock Incentive Plan, increasing available shares by 3.7 million, alongside director elections and auditor ratification.
Capital raise
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation reported mixed first-quarter 2026 financial results, with revenue increasing but GAAP operating income and net income declining year-over-year, while maintaining its full-year outlook.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation has amended its accounts receivable securitization facility, increasing available borrowings to $750 million and extending the termination date to March 20, 2028.
Better than expected
Capital raise
Quarterly Earnings (10-Q)
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation reported a 1.9% revenue increase for Q2 2026, reaching $2.46 billion, but net income declined to $55.3 million due to significant restructuring costs.
Worse than expected
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation reported a 5.4% increase in revenue for the first quarter of fiscal year 2026, driven by growth in retail and financial services, but saw a significant decrease in net income and operating income.
Worse than expected
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation announced significant increases in net income and EPS for Q3 2025, driven by improved operating efficiency and favorable foreign currency impacts, alongside a dividend hike and debt refinancing.
Better than expected
Capital raise
NASDAQ
CNXC
Concentrix CORP10-Q: Concentrix Reports Mixed Q2 2025 Results Amidst Revenue Growth Slowdown and Non-Operating Headwinds
Concentrix Corporation reported a 1.5% increase in revenue for the three months ended May 31, 2025, but experienced a significant decline in net income and diluted EPS, primarily due to increased non-operating expenses, while demonstrating strong cash flow generation and proactive debt management.
Worse than expected
Capital raise
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation's Q1 2025 results show a slight revenue decrease year-over-year, but operating income increased due to lower administrative expenses.
Worse than expected
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation's third quarter results for 2024 show a significant increase in revenue due to the Webhelp acquisition, but also a decrease in operating income and earnings per share.
Worse than expected
Annual Reports (10-K)
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation reported a significant net loss of $1.28 billion for fiscal year 2025, primarily driven by a $1.52 billion goodwill impairment charge, despite a 2.2% revenue increase.
Worse than expected
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation's 2024 annual report details a year of significant growth, driven by strategic acquisitions and investments in technology, while also navigating economic and industry challenges.
Worse than expected
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation's 10-K filing details the company's common stock, preferred stock authorization, anti-takeover provisions, and liability limitations for directors and officers.
Insider Trading (Form 4)
NASDAQ
CNXC
Concentrix CORPChristopher A. Caldwell, President and CEO of Concentrix Corp, acquired 1,000 shares of common stock.
NASDAQ
CNXC
Concentrix CORPConcentrix Corp reports a Form 4 filing detailing the acquisition of 2,500 common shares by Chief Financial Officer Andre S. Valentine.
NASDAQ
CNXC
Concentrix CORPConcentrix Corp's President and CEO, Christopher A. Caldwell, purchased 1,000 shares of common stock at $26.97 per share.
NASDAQ
CNXC
Concentrix CORPConcentrix Corp. Director LaVerne H. Council received an award of 7,701 restricted stock units, increasing her beneficial ownership to 17,704 shares.
NASDAQ
CNXC
Concentrix CORPConcentrix Corp Director Chih-Kai Cheng received an award of 7,701 restricted stock units, vesting based on time or the 2027 Annual Meeting.
NASDAQ
CNXC
Concentrix CORPConcentrix Corp Director Bilge Ogut was granted 7,701 restricted stock units, aligning interests with shareholders.
Proxy Statements (Def-14A)
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation has voluntarily amended its definitive proxy statement to clarify voting treatment for Proposal No. 4, addressing a stockholder demand letter.
Delay expected
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation's 2025 Annual Meeting will be held virtually on March 25, 2025, with stockholders voting on director elections, auditor ratification, executive compensation, and amendments to corporate governance.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation will hold its 2025 Annual Meeting of Stockholders virtually on March 25, 2025, to vote on the election of directors, ratification of the accounting firm, executive compensation, and charter amendments.
Worse than expected
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation issues a supplement to its proxy statement to clarify voting requirements and the effect of abstentions for the upcoming Special Meeting of Stockholders on October 28, 2024.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation is holding a special meeting on October 28, 2024, for shareholders to vote on proposals to amend the company's charter and stock incentive plan.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation is holding a special meeting to vote on proposals to amend its charter and restate its stock incentive plan.
Schedule 13D - Activist Investments
NASDAQ
CNXC
Concentrix CORPGroupe Bruxelles Lambert and its affiliates have sold a significant block of Concentrix shares, reducing their ownership below the 5% reporting threshold.
NASDAQ
CNXC
Concentrix CORPGroupe Bruxelles Lambert updated its Schedule 13D filing for Concentrix Corporation, reflecting a 14.24% beneficial ownership stake and outlining investor rights.
NASDAQ
CNXC
Concentrix CORPImpactive Capital LP and its affiliates have significantly reduced their beneficial ownership in Concentrix Corp, now holding 4.9% of common stock.
Worse than expected
Schedule 13G - Passive Investments
NASDAQ
CNXC
Concentrix CORPAQR Capital Management, LLC and AQR Capital Management Holdings, LLC have reported beneficial ownership of 7.94% of Concentrix Corp's common stock as of March 31, 2026.
NASDAQ
CNXC
Concentrix CORPFMR LLC and Abigail P. Johnson have reported beneficial ownership of 4,223,281.76 shares, representing 6.9% of Concentrix Corp's common stock as of March 31, 2026.
NASDAQ
CNXC
Concentrix CORPSynnex Technology International Corporation has filed a Schedule 13G, reporting beneficial ownership of 4,369,475 shares of Concentrix Corp. common stock, representing 7.1% of the class.
NASDAQ
CNXC
Concentrix CORPThe Vanguard Group has reported a 0% beneficial ownership in Concentrix Corp following an internal realignment.
NASDAQ
CNXC
Concentrix CORPAQR Capital Management, LLC and its parent company have reported a 4.74% beneficial ownership stake in Concentrix Corp, totaling 2,950,287 shares.
NASDAQ
CNXC
Concentrix CORPAQR Capital Management and its holding company have disclosed a 6.83% beneficial ownership stake in Concentrix Corp, totaling 4,305,469 shares.